Dr. Anthony J. Sinskey

University of Illinois at Urbana-Champaign, BS, 1962

Massachusetts Institute of Technology, ScD, 1966

Anthony J. Sinskey, Sc.D., is a Professor of Microbiology at the Massachusetts Institute of Technology and holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership Program and as Faculty Director of the MIT Center for Biomedical Innovation (CBI). He conducts interdisciplinary research in metabolic engineering focusing on the fundamental physiology, biochemistry and molecular genetics of important organisms. Dr. Sinskey is well known in the biopharmaceutical industry and has been a Scientific Co-founder of several biotechnology companies, including Genzyme Corporation, Natural Pharmaceuticals, Metabolix, Merrimack Pharmaceuticals, and Tepha. Dr. Sinskey has given more than 300 presentations at U.S. and International scientific meetings and congresses. He has received 31 issued patents, has made more than 30 invention disclosures and has published more than 300 scientific papers in leading peer-reviewed journals for biology, metabolic engineering, and biopolymer engineering.